Volume 7 (2020): Issue 1

Clinical profile of children with haemophilia at the University Hospital of Brazzaville

Open Access | | Creative Commons Attribution NonCommercial NoDerivatives
FO Galiba Atipo Tsiba ORCID iD
OL Ngolet ORCID iD
NY Ngakengni
LC Ollandzobo Ikobo
JV Nziengui-Mboumba
A Elira Dokekias

Abstract

Abstract Introduction

Haemophilia is a rare hereditary haemorrhagic disease caused by coagulation factor VIII (haemophilia A) or IX (haemophilia B) deficiency. Very few data exist on this disease in Congo. This survey aims to describe the epidemiological and clinical aspects of the children affected.

Materials and methods

A descriptive cross-sectional study was carried out in the haematology department of the Brazzaville University Hospital over a period of two years. Children (under 18 years of age) with haemophilia and with a factor VIII or IX level less than or equal to 30% were identified. The parameters analysed included age, diagnostic delay, type and severity of haemophilia, type and frequency of bleeding manifestations, complications and history of transfusion.

Results

Nineteen patients were identified with an average age at diagnosis of four years. The average time to diagnosis was six years, and the most frequent first known bleeding episode was haemorrhage during circumcision. Family history was found in 14 cases. There were 13 cases of haemophilia A and six cases of haemophilia B. Fourteen cases were severe haemophilia; no mild cases were identified. Haemorrhagic manifestations included haemarthrosis, haematomas and mucocutaneous haemorrhages. The average number of haemorrhagic episodes per year was 12. Haemophilic arthropathy was present at diagnosis in seven cases, with the main location being the knee. The average number of hospitalisations before diagnosis was two. Sixteen patients had been transfused at least once.

Conclusion

Although circumcision is the most frequent first known haemorrhagic manifestation of haemophilia in Congo, patients are often diagnosed late, sometimes with severe osteoarticular complications. Further measures are needed to help ensure early diagnosis and improve care.

Article

View Full Article

References

  • 1. Franchini M, Mannucci PM. Past, present and future of hemophilia: a narrative review. Orphanet J Rare Dis 2012; 7: 24. doi: https://doi.org/10.1186/1750-1172-7-24.
  • 2. Carcao MD. The diagnosis and management of congenital hemophilia. Semin Thromb Hemost 2012; 38: 727–34. doi: https://doi.org/10.1055/s-0032-1326786.
  • 3. Iorio A, Stonebraker JS, Chambost H, et al; Data and Demographics Committee of the World Federation of Hemophilia. Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries. Ann Intern Med 2019; 171: 540–46. doi: https://doi.org/10.7326/M19-1208.
  • 4. Diop S, Haffar A, Mahlangu J, et al. Improving access to hemophilia care in sub-Saharan Africa by capacity building. Blood Adv 2019; 3(Suppl 1): 1–14. doi: https://doi.org/10.1182/bloodadvances.2019GS121537.
  • 5. Diop S, Seck M, Sy-Bah D, et al. Implementing haemophilia care in Senegal, West Africa Haemophilia 2014; 20(1): 73–7. doi: https://doi.org/10.1111/hae.12249.
  • 6. Lambert C, Meité N, Sanogo I, et al. Haemophilia in Côte d'Ivoire (the Ivory Coast) in 2017: extensive data collection as part of the World Federation of Hemophilia's twinning programme. Haemophilia 2019; 25(2): 236–43. doi: https://doi.org/10.1111/hae.13682.
  • 7. Tagny CT, Moudourou S, Ndoumba A, Mbanya D. Hemophilia in developing countries: an analysis of the first data in Cameroon, Africa. J Blood Lymph 2014; 4: 119. doi:https://doi.org/10.4172/2165-7831.1000119.
  • 8. Benajiba N, Boussaadni YE, Aljabri M, Bentata Y, Amrani R, Rkain M. Hémophilie: état des lieux dans un service de pédiatrie dans la région de l’oriental du Maroc. Pan Afr Med J. 2014; 18: 126. https://doi.org/10.11604/pamj.2014.18.126.4007.
  • 9. Okoye HC, Korubo KI, Nwogoh B, Efobi CC, Ugwu NI, Madu AJ. Challenges in the management of bleeding disorders in Nigeria. Niger J Clin Pract 2018; 21: 468–72. doi: https://doi.org/10.4103/njcp.njcp_319_17.
  • 10. Global Health Workforce Alliance. Reviewing progress, renewing commitment: progress report on the Kampala Declaration and Agenda for Global Action. Global Health Workforce Alliance. World Health Organization, 2011. Available from https://www.who.int/workforcealliance/knowledge/resources/kdagaprogressreport/en/ (accessed 17 April 2020).
  • 11. World Federation of Hemophilia. Introduction to hemophilia. Available from https://elearning.wfh.org/elearning-centres/introduction-to-hemophilia/ (accessed 20 April 2020).
  • 12. Mou XL, Zhao Y, Chen ZH, Ding YQ, Li M, Jia MF, Xi YM. [Clinical characteristics of 223 Chinese patients with hemophilia in a medical center of Gansu Province in China]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2016; 24(5): 1495–99. doi: https://doi.org/10.7534/j.issn.1009-2137.2016.05.038.
  • 13. Kulkarni R, Soucie JM, Lusher J, et al.; Haemophilia Treatment Center Network Investigators. Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project. Haemophilia 2009; 15: 1281–90. doi: https://doi.org/10.1111/j.1365-2516.2009.02074.x.
  • 14. Aronstam A, Rainsford SG, Painter MJ. Patterns of bleeding in adolescents with severe haemophilia A. Br Med J 1979; 1: 469–70.
  • 15. Pergantou H, Matsinos G, Papadopoulos A, et al. Comparative study of validity of clinical, X-ray and magnetic resonance imaging scores in evaluation and management of haemophilic arthropathy in children. Haemophilia 2006; 12(3): 241–7.
  • 16. Pierce GF, Haffar A, Ampartzidis G, et al. First-year results of an expanded humanitarian aid programme for haemophilia in resource-constrained countries. Haemophilia 2018; 24(2): 229–235. doi: https://doi.org/10.1111/hae.13409.

PDF Download

Download PDF

Open in full-page viewer

Authors

  • FO Galiba Atipo Tsiba

    ORCID iD
    atipogaliba@gmail.com
    Haematology Department, University Hospital of Brazzaville ; Faculty of Health Sciences, Marien Ngouabi University of Brazzaville, Congo .

  • OL Ngolet

    ORCID iD
    Haematology Department, University Hospital of Brazzaville ; Faculty of Health Sciences, Marien Ngouabi University of Brazzaville, Congo

  • NY Ngakengni

    Paediatric Department, University Hospital of Brazzaville ; Faculty of Health Sciences, Marien Ngouabi University of Brazzaville, Congo

  • LC Ollandzobo Ikobo

    Paediatric Department, University Hospital of Brazzaville ; Faculty of Health Sciences, Marien Ngouabi University of Brazzaville, Congo

  • JV Nziengui-Mboumba

    Haematology Department, University Hospital of Brazzaville, Congo

  • A Elira Dokekias

    Haematology Department, University Hospital of Brazzaville ; Faculty of Health Sciences, Marien Ngouabi University of Brazzaville, Congo